ENGOT-en11/GOG-3053/KEYNOTE-B21: Phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer.Toon Van Gorp,Mansoor Raza Mirza,Alain Lortholary,David Cibula,Axel Walther,Antonella Savarese,Maria Pilar Barretina-Ginesta,Firat Ortac,Christos Papadimitriou, Lubomir Bodnar,Chyong-Huey Lai,Jacob Korach,Christian Marth,Kosei Hasegawa,Xing Xie,Emma L. Barber,Robert L. Coleman,Stephen Michael Keefe,Robert Orlowski,Brian SlomovitzJOURNAL OF CLINICAL ONCOLOGY(2021)引用 6|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要